Clincosm LogoSign in Get a demo

COVID-19

Showing NaN - NaN of 84
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in United States (Acalabrutinib)

Completed
Has Results
  • COVID-19
  • Anniston, Alabama
  • +30 more
Sep 8, 2021

COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)

Completed
  • COVID-19
  • PUL-042 Inhalation Solution
  • Placebo
  • Orange, California
  • +14 more
Sep 1, 2021

Predictors of Severe COVID-19 Outcomes

Active, not recruiting
  • Acute Respiratory Distress Syndrome
  • COVID-19
    • Tucson, Arizona
    • +7 more
    Aug 16, 2021

    COVID-19 Trial in Houston (GS-441524)

    Completed
    • COVID-19
    • Houston, Texas
      Copycat Sciences Study Site
    Aug 7, 2021

    COVID-19 Trial in United States (PUL-042 Inhalation Solution, Placebo)

    Completed
    • COVID-19
    • PUL-042 Inhalation Solution
    • Placebo
    • Orange, California
    • +10 more
    Jul 14, 2021

    COVID-19, Viral Respiratory Illnesses Trial in United States (Nitazoxanide, Placebo, Vitamin Super B-Complex)

    Unknown status
    • COVID-19
    • Viral Respiratory Illnesses
    • Hot Springs, Arkansas
    • +25 more
    Feb 5, 2021

    COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)

    Completed
    Has Results
    • COVID-19
    • Anaheim, California
    • +183 more
    Jan 21, 2021

    COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)

    Completed
    Has Results
    • COVID-19
    • Anaheim, California
    • +182 more
    Dec 15, 2020

    COVID-19 Trial in United States (Merimepodib, Matching Placebo, Remdesivir)

    Terminated
    • COVID-19
    • Phoenix, Arizona
    • +9 more
    Dec 4, 2020